MedPath

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

Recruiting
Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
Device: C-Rex Instrument
Registration Number
NCT06615661
Lead Sponsor
Iantrek, Inc.
Brief Summary

This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.

Detailed Description

This a multicenter, observational real-world evidence study of eligible adults with primary open angle glaucoma (POAG) in whom ab-interno goniotomy surgery with the C-Rex Instrument was performed.

Data is collected from the preoperative visit(s) that directly preceded the surgery, the surgical procedure, and post-surgical visits through 12 months postoperatively.

Specific data collected includes C-Rex Instrument goniotomy surgical details, preoperative and postoperative IOP and use of ocular hypotensive medications, and device-related safety events.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Primary open angle glaucoma
  • Goniotomy surgery performed using the C-Rex Instrument
Exclusion Criteria
  • History of intraocular surgery within 8 weeks prior to C-Rex surgery
  • Preoperative IOP higher than 33 mmHg
  • Presence of a glaucoma type other than POAG
  • Presence of clinically significant intraocular pathology other than cataract or glaucoma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
C-Rex surgery - combinationC-Rex InstrumentC-Rex surgery combined with cataract extraction/intraocular lens (IOL) implantation
C-Rex surgery - standaloneC-Rex InstrumentC-Rex surgery as a standalone intervention
Primary Outcome Measures
NameTimeMethod
Percent of eyes with intraocular pressure (IOP)reduction ≥20%in comparison with baseline.12 month postoperative

Intraocular pressure (IOP) is at least 20% lower than before surgery without additional ocular hypotensive medications or IOP-lowering surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Omni Eye Services

🇺🇸

Atlanta, Georgia, United States

CIRCLE Site 04

🇺🇸

Crossville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath